Camilla Soenderby

This profile gathers the share dealings of Camilla Soenderby in Abivax, where the filings describe the role as board member. The record holds 2 filings, for trades running from 26 April 2024 to 13 February 2026.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 18 February 2026 came the latest disclosure, a transaction for €155k in Abivax. These figures are compiled from regulatory filings published by AMF. They describe what insiders did and are not a recommendation.